These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 16302294)
1. Looking at US versus European exit opportunities. Lawrence S Nat Biotechnol; 2005 Oct; 23(10):1203. PubMed ID: 16302294 [No Abstract] [Full Text] [Related]
2. The rise of European venture capital for biotechnology. Howell M; Trull M; Dibner MD Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356 [No Abstract] [Full Text] [Related]
3. Biotech IPOs--flop or pop? Jacobs T Nat Biotechnol; 2004 Aug; 22(8):949. PubMed ID: 15286641 [No Abstract] [Full Text] [Related]
4. Mind the (biomedical funding) gap. Klausner A Nat Biotechnol; 2005 Oct; 23(10):1217-8. PubMed ID: 16211055 [No Abstract] [Full Text] [Related]
5. Mixed results in Q1. Lawrence S Nat Biotechnol; 2005 May; 23(5):518. PubMed ID: 15877059 [No Abstract] [Full Text] [Related]
6. VC funding hits high in Q1. Lawrence S Nat Biotechnol; 2007 May; 25(5):496. PubMed ID: 17483825 [No Abstract] [Full Text] [Related]
7. US venture capital for biotechnology. Dibner MD; Trull M; Howell M Nat Biotechnol; 2003 Jun; 21(6):613-7. PubMed ID: 12776144 [No Abstract] [Full Text] [Related]
10. Divining the path to a successful European exit. Buch HK; Gustafsson AC; Drvota V; Sundberg CJ Nat Biotechnol; 2011 Mar; 29(3):205-7. PubMed ID: 21510008 [No Abstract] [Full Text] [Related]
11. Companies jostle for access to public markets. Bouchie A Nat Biotechnol; 2003 Dec; 21(12):1413-4. PubMed ID: 14647309 [No Abstract] [Full Text] [Related]